PURE Bioscience's PURE(R) Hard Surface Disinfectant -- Revolutionizing Restaurant Chain Food Safety With Superior Effective Solution to Foodborne Illness
Proven Fast Kill of Norovirus, E. coli, Salmonella and Listeria -- Provides 24-Hour Residual Protection
SAN DIEGO, CA--(Marketwired - Jan 8, 2016) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today discussed its best-in-class food safety solutions for eliminating pathogens in restaurant operations, including Norovirus, E. coli, Salmonella and Listeria. PURE's recent traction in its sales and marketing outreach to restaurant chains highlights the proven superior safety and efficacy of the PURE Total Solution: SDC-based PURE® Hard Surface food contact surface disinfectant plus recently FDA approved PURE Control® (for use directly on fresh produce or raw poultry during processing).
PURE Hard Surface - Restaurant Food Safety Solution
PURE is revolutionizing restaurant food safety with the most effective, user friendly antimicrobial disinfectant available. Proven in extensive testing, it eliminates a broader range of microorganisms in restaurant operations faster and more safely than sanitizers currently in use today.
Superior efficacy -- 96% improved overall sanitation vs. leading competitor's quaternary ammonia product.
Eliminates Norovirus in 60 seconds -- a leading cause of foodborne illness outbreaks in the US.
Norovirus is not eliminated by competitive sanitizers as conventionally used today.
Faster kill against Listeria, E. coli, Salmonella and other foodborne pathogens.
24-hour residual protection.
Mitigates bacterial resistance.
Lowest toxicity -- user and environment friendly.
Restaurant customers using PURE Hard Surface disinfectant presently include:
Two Casual Dining chains and one Quick Service Restaurant (QSR) chain which have recently adopted PURE Hard Surface to fight Norovirus.
Four additional chains are in the midst of the evaluation process.
SUBWAY® Restaurants* use in approx. 7,100 stores (25% penetration) to date on food contact surfaces including produce slicers, cutting/sandwich board, prep tables and dining tables. The product has recently been approved for expanded use on ice machines -- and is being evaluated for additional areas of use.
Hank R. Lambert, CEO of PURE said, "Norovirus is the leading cause of foodborne illness outbreaks in restaurants. It has gained heightened visibility in the media recently, most notably with the Chipotle Mexican Restaurants outbreaks that have led to a Federal Grand Jury investigation. The impact that these outbreaks can have on human health as well as a company's brand is devastating. Use of PURE Hard Surface by restaurant chains can provide superior protection against Norovirus versus products currently being used... and go a long way toward providing safer food for consumers and protecting the restaurant's most valuable asset -- its brand."
* SUBWAY® is a registered trademark of Doctor's Associates Inc.
About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and it mitigates bacterial resistance. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company's PURE Hard Surface and the Company's ability to convert successful evaluations into customer orders; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw poultry and raw meat processing; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2015 and its Form 10-Q for the first quarter ended October 31, 2015. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Contacts:
Hank Lambert
CEO
PURE Bioscience, Inc.
619-596-8600 ext.103
Email Contact
Terri MacInnis
VP of IR
Bibicoff + MacInnis, Inc.
818-379-8500
Email Contact
Tom Hemingway
Redwood Investment Group
714-978-4425
Email Contact
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
OTC Markets
Our Marketplaces
Market Info
Contact Us
Advertising
Market Hours/Holidays
Corporate Info
About Us
Investor Relations
Press Center
Careers
Sign up for the Newsletter
View Previous Newsletters
Follow Us:
© 2016 OTC Markets Group Inc.Terms of ServiceLinking TermsTrademarksPrivacy StatementRisk WarningSite MapGive FeedbackSupported Browsers↑ Jump to Top
OTC Link® ATS provided by OTC Link LLC, member FINRA / SIPC, a wholly owned subsidiary of OTC Markets Group Inc.
OTCQX, OTCQB and OTC Pink marketplaces designated by OTC Markets Group.
AdTech Ad
Proven Fast Kill of Norovirus, E. coli, Salmonella and Listeria -- Provides 24-Hour Residual Protection
SAN DIEGO, CA--(Marketwired - Jan 8, 2016) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today discussed its best-in-class food safety solutions for eliminating pathogens in restaurant operations, including Norovirus, E. coli, Salmonella and Listeria. PURE's recent traction in its sales and marketing outreach to restaurant chains highlights the proven superior safety and efficacy of the PURE Total Solution: SDC-based PURE® Hard Surface food contact surface disinfectant plus recently FDA approved PURE Control® (for use directly on fresh produce or raw poultry during processing).
PURE Hard Surface - Restaurant Food Safety Solution
PURE is revolutionizing restaurant food safety with the most effective, user friendly antimicrobial disinfectant available. Proven in extensive testing, it eliminates a broader range of microorganisms in restaurant operations faster and more safely than sanitizers currently in use today.
Superior efficacy -- 96% improved overall sanitation vs. leading competitor's quaternary ammonia product.
Eliminates Norovirus in 60 seconds -- a leading cause of foodborne illness outbreaks in the US.
Norovirus is not eliminated by competitive sanitizers as conventionally used today.
Faster kill against Listeria, E. coli, Salmonella and other foodborne pathogens.
24-hour residual protection.
Mitigates bacterial resistance.
Lowest toxicity -- user and environment friendly.
Restaurant customers using PURE Hard Surface disinfectant presently include:
Two Casual Dining chains and one Quick Service Restaurant (QSR) chain which have recently adopted PURE Hard Surface to fight Norovirus.
Four additional chains are in the midst of the evaluation process.
SUBWAY® Restaurants* use in approx. 7,100 stores (25% penetration) to date on food contact surfaces including produce slicers, cutting/sandwich board, prep tables and dining tables. The product has recently been approved for expanded use on ice machines -- and is being evaluated for additional areas of use.
Hank R. Lambert, CEO of PURE said, "Norovirus is the leading cause of foodborne illness outbreaks in restaurants. It has gained heightened visibility in the media recently, most notably with the Chipotle Mexican Restaurants outbreaks that have led to a Federal Grand Jury investigation. The impact that these outbreaks can have on human health as well as a company's brand is devastating. Use of PURE Hard Surface by restaurant chains can provide superior protection against Norovirus versus products currently being used... and go a long way toward providing safer food for consumers and protecting the restaurant's most valuable asset -- its brand."
* SUBWAY® is a registered trademark of Doctor's Associates Inc.
About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and it mitigates bacterial resistance. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company's PURE Hard Surface and the Company's ability to convert successful evaluations into customer orders; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw poultry and raw meat processing; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2015 and its Form 10-Q for the first quarter ended October 31, 2015. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Contacts:
Hank Lambert
CEO
PURE Bioscience, Inc.
619-596-8600 ext.103
Email Contact
Terri MacInnis
VP of IR
Bibicoff + MacInnis, Inc.
818-379-8500
Email Contact
Tom Hemingway
Redwood Investment Group
714-978-4425
Email Contact
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
OTC Markets
Our Marketplaces
Market Info
Contact Us
Advertising
Market Hours/Holidays
Corporate Info
About Us
Investor Relations
Press Center
Careers
Sign up for the Newsletter
View Previous Newsletters
Follow Us:
© 2016 OTC Markets Group Inc.Terms of ServiceLinking TermsTrademarksPrivacy StatementRisk WarningSite MapGive FeedbackSupported Browsers↑ Jump to Top
OTC Link® ATS provided by OTC Link LLC, member FINRA / SIPC, a wholly owned subsidiary of OTC Markets Group Inc.
OTCQX, OTCQB and OTC Pink marketplaces designated by OTC Markets Group.
AdTech Ad
